Managed Healthcare Executive April 16, 2024
Peter Wehrwein, Managing Editor

Ross Margulies, J.D., M.P.H., a partner at the Foley Hoag law firm, says there is broad agreement on transparency provisions and a ban on spread pricing in Medicaid.

After years of federal inaction, momentum started to build last year for legislation would impose new rules on the pharmacy benefit manager (PBM) industry. Many observers expect a bill to pass this year, during this Congress, although perhaps not until the lame-duck session after the Nov. 5 election. But what that bill will include is still far from certain, with various interest groups and ideas jostling for position and influence over what does and does not get included.

Ross Margulies, J.D., M.P.H., a partner in the Foley Hoag law firm, spoke about...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Trends
Project Optimus: helping or hindering cancer drug development?
Faster Drug Discovery: Yseop & AWS Unveils GenAI Tool for Biopharma R&D
Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab
STAT+: Gilead gets a boost from California court in a case over slow-walking an HIV drug
Specialty Pharmacies Drive Cost Savings in Value-Based Care | Asembia 2024

Share This Article